News

LGC remains the highest ranked life sciences company in the league table.

Kit designed to measure day-to-day performance of the assay providing positive and negative reference solution.

First commercially cvailable SARS-CoV-2 antibody test in UK compatible with Neoteryx’s Mitra® Microsampling Device for at-home blood collection

LGC has announced three new senior appointments

M4R will run until the end of 2020 and will enable businesses to have access to the world-leading chemical and bio-measurement expertise and capabilities at the NML.

First large-scale production run of Apta-1as a non-GMP material, intended for use in GLP toxicology studies

A proposal that could bring £60million investment into the life sciences sector in Kent has taken a significant stride forward by securing £50,000 to develop the bid further. The money is seedcorn funding via UK Research and Innovation’s flagship £236m Strength in Places Fund.

Bearing the CE mark and IVD symbol signifies that the AccuPlex SARS-CoV-2 Molecular Controls Kit meets extensive design control requirements.

Proficiency testing (PT), often known as External Quality Assessment (EQA) in the clinical sector, allows laboratories to assess their measurement processes with test materials that we send them.

Expansion allows for compatibility with any SARS-CoV-2 assay target, while maintaining safety features

Acquisition strengthens LGC’s existing product offering to IVD sector, which includes quality assurance tools, immunoassay reagents and disease state plasma.

The National Measurement Laboratory (NML), hosted at LGC, welcomes the publication of the UK government’s Research and Development (R&D) Roadmap with its ongoing commitment to increased investment in R&D to cement the UK’s world-leading position within science and research and support the individuals behind it.